Thomas Colace
About Thomas Colace
Thomas Colace serves as the Director of LNP Formulation at Tessera Therapeutics, where he has worked since 2022. He holds a PhD in Chemical and Biomolecular Engineering from the University of Pennsylvania and has extensive experience in the biotechnology field, including previous roles at Kernal Biologics, Verve Therapeutics, and Merck.
Current Role at Tessera Therapeutics
Thomas Colace serves as the Director of LNP Formulation at Tessera Therapeutics. He has held this position since 2022, contributing to the development of lipid nanoparticle formulations. His work focuses on advancing therapeutic delivery systems, which are crucial for the effectiveness of various treatments.
Previous Experience at Kernal Biologics
Before joining Tessera Therapeutics, Thomas Colace worked at Kernal Biologics as Associate Director of LNP Formulation from 2021 to 2022. In this role, he was involved in the formulation and development of lipid nanoparticle technologies, enhancing the company's capabilities in biotherapeutics.
Education and Expertise
Thomas Colace earned his Doctor of Philosophy (PhD) in Chemical and Biomolecular Engineering from the University of Pennsylvania, where he studied from 2008 to 2013. He also holds a Bachelor of Science (B.S.) in Chemical Engineering from Northwestern University, completed from 2004 to 2008. His educational background provides a strong foundation in engineering principles applicable to biopharmaceutical development.
Career Path and Previous Roles
Thomas Colace's career includes significant roles in various organizations. He was an Associate Principal Scientist at Verve Therapeutics from 2019 to 2021, where he focused on innovative therapeutic approaches. Prior to that, he worked as a Senior Scientist at Merck from 2014 to 2019, contributing to drug development efforts. His early career included a postdoctoral research position at the University of Pennsylvania from 2013 to 2014.